Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).
Publication
, Journal Article
Parikh, KS; Lippmann, SJ; Greiner, M; Heidenreich, PA; Yancy, CW; Fonarow, GC; Hernandez, AF
Published in: Circulation
May 23, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
May 23, 2017
Volume
135
Issue
21
Start / End Page
2077 / 2080
Location
United States
Related Subject Headings
- Valsartan
- Tetrazoles
- Registries
- Practice Guidelines as Topic
- Middle Aged
- Male
- Humans
- Hospitalization
- Heart Failure
- Female
Citation
APA
Chicago
ICMJE
MLA
NLM
Parikh, K. S., Lippmann, S. J., Greiner, M., Heidenreich, P. A., Yancy, C. W., Fonarow, G. C., & Hernandez, A. F. (2017). Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). Circulation, 135(21), 2077–2080. https://doi.org/10.1161/CIRCULATIONAHA.117.027773
Parikh, Kishan S., Steven J. Lippmann, Melissa Greiner, Paul A. Heidenreich, Clyde W. Yancy, Gregg C. Fonarow, and Adrian F. Hernandez. “Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).” Circulation 135, no. 21 (May 23, 2017): 2077–80. https://doi.org/10.1161/CIRCULATIONAHA.117.027773.
Parikh KS, Lippmann SJ, Greiner M, Heidenreich PA, Yancy CW, Fonarow GC, et al. Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). Circulation. 2017 May 23;135(21):2077–80.
Parikh, Kishan S., et al. “Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).” Circulation, vol. 135, no. 21, May 2017, pp. 2077–80. Pubmed, doi:10.1161/CIRCULATIONAHA.117.027773.
Parikh KS, Lippmann SJ, Greiner M, Heidenreich PA, Yancy CW, Fonarow GC, Hernandez AF. Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). Circulation. 2017 May 23;135(21):2077–2080.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
May 23, 2017
Volume
135
Issue
21
Start / End Page
2077 / 2080
Location
United States
Related Subject Headings
- Valsartan
- Tetrazoles
- Registries
- Practice Guidelines as Topic
- Middle Aged
- Male
- Humans
- Hospitalization
- Heart Failure
- Female